FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
For this study, the author’s identified 10 procedures (9 patients including one staged bilateral removal). The mean BMI was 37.3, mean ASA was 2.7 and all patients had previously undergone abdominal surgery. The indications for robotic assistance included: need for concomitant kidney surgery such as pyeloplasty (n=4), severe morbid obesity with large stone burden (mean BMI 57; n=3), contractures limiting position for ureteroscopy or PCNL (n=1), calyceal diverticular stone (n=1), and patient preference (n=1). There were a mean 2.2 stones per side and a mean stone volume of 14.9 cm3 (range 0.8- 75 cm3). The mean operative time was 175 minutes, mean EBL was 54 cc, and mean length of stay was 3.2 days. Three patients had post-operative complications, including need for stent repositioning, stent replacement following removal, post-operative discharge on home oxygen. Over a mean follow-up of 58 days, the stent was left indwelling for a mean 42 days, and there were four patients with adequate post-operative imaging, 3 of which were completely stone free.
The authors concluded that robotic assisted pyelolithotomy or nephrolithotomy are feasible in highly selected patients.
Presented By: Morris Jessop, West Virginia University Hospital, Morgantown, WV
Co-Authors: Leor Arbel, Chad Crigger, John Barnard, Mohamad Salkini
Written By: Zachary Klaassen, MD, Urologic Oncology Fellow, University of Toronto, Princess Margaret Cancer Centre, @zklaassen_md ,at the 2018 North American Robotic Urology Symposium, February 16-17, 2018 - Las Vegas, NV
1. Swearingen R, Sood A, Madi R, Klaassen Z, et al. Zero-fragment nephrolithotomy: A Multi-center evaluation of robotic pyelolithotomy and nephrolithotomy for treating renal stones. Eur Urol 2017 Dec;72(6):1014-1021.
2. King SA, Klaassen Z, Madi R. Robot-assisted anatrophic nephrolithotomy: Description of technique and early results. J Endourol 2014;28(3):325-329.